Cohort plc (AIM:CHRT)
1,065.00
-10.00 (-0.93%)
Feb 21, 2025, 6:14 PM GMT+1
Cohort Revenue
Cohort had revenue of 118.24M GBP in the half year ending October 30, 2024, with 52.63% growth. This brings the company's revenue in the last twelve months to 226.47M, up 13.49% year-over-year. In the fiscal year ending April 30, 2024, Cohort had annual revenue of 202.53M with 10.85% growth.
Revenue (ttm)
226.47M
Revenue Growth
+13.49%
P/S Ratio
1.90
Revenue / Employee
161.76K
Employees
1,309
Market Cap
481.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 202.53M | 19.82M | 10.85% |
Apr 30, 2023 | 182.71M | 44.95M | 32.63% |
Apr 30, 2022 | 137.77M | -5.54M | -3.87% |
Apr 30, 2021 | 143.31M | 12.25M | 9.35% |
Apr 30, 2020 | 131.06M | 9.88M | 8.15% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
RELX PLC | 9.43B |
Rolls-Royce Holdings | 17.82B |
BAE Systems | 26.31B |
Experian | 5.45B |
Ashtead Group | 8.53B |
International Consolidated Airlines Group | 26.03B |
Halma | 2.16B |
Rentokil Initial | 5.41B |
Cohort News
- 17 days ago - Cohort plc: High Growth Aerospace And Defense Play With Steep Valuation - Seeking Alpha
- 19 days ago - Cohort expands global reach Down Under with new acquisition - The Armchair Trader
- 7 weeks ago - U.S. Global Launches Technology And Aerospace & Defense ETF: Why Its Allocation Makes Sense - Benzinga
- 2 months ago - Half Year 2025 Cohort PLC Earnings Presentation Transcript - GuruFocus
- 2 months ago - Half Year 2025 Cohort PLC Analyst presentation Q&A Transcript - GuruFocus
- 3 months ago - Visa Accelerator Program Africa selects Cohort 3 - Zawya
- 5 months ago - Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients - Benzinga
- 5 months ago - Hub71 welcomes 21 startups in 15th Cohort to Abu Dhabi that have raised over $130mln in funding - Zawya